Moderna locks up Spikevax name in Europe, joins Pfizer's Comirnaty in wait for...

cafead

Administrator
Staff member
  • cafead   Jun 30, 2021 at 11:32: AM
via Spikevax it is. Moderna has earned European Medicine Association approval for the brand name of its COVID-19 vaccine, even as it awaits an FDA decision.

With last week's official nod in the EU, Moderna's Spikevax joins Pfizer and BioNTech’s Comirnaty and AstraZeneca’s Vaxzevria with European brand-name approvals. None of the names is approved in the U.S., though, because the vaccines are still under emergency use authorization rather than bearing full FDA approval.

article source
 

<